Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2023-07-12 00:00:00 ET · period of report 2023-07-10 · accession 0001662579-23-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-12 | 2023-07-10 | CCCC | REYNO LEONARD | Chief Medical Off | A - Grant | $0.00 | +61.3K | 61.3K | New | $0 |
| D | 2023-07-12 | 2023-07-10 | CCCC | REYNO LEONARD | Chief Medical Off | A - Grant | $0.00 | +276.0K | 276.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-10 | A | A | 61,300 | $0.00 | 61,300 | D | — | — | (F1) Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on July 10, 2024, subject to the Reporting Person's continued service on each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-07-10 | A | A | 276,000 | $0.00 | 276,000 | D | $3.50 · — to 2033-07-09 | 276,000 Common Stock | (F2) 25% of the shares underlying this option shall vest and become exercisable on July 10, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |